LNP Encapsulation
Lipid Nanoparticles (LNPs), as a next-generation delivery platform, utilize lipid molecular self-assembly to create nano-scale encapsulation systems. This technology significantly enhances drug stability and targeting efficacy.
Levostar Biotech has established a fully integrated technology platform covering gene synthesis, plasmid preparation, mRNA synthesis, and LNP encapsulation, with breakthrough capabilities in efficient delivery of circular RNA (circRNA) and self-amplifying RNA (saRNA). We provide full-cycle solutions from sequence design to final product scale-up for innovative drug development
Service Advantages
·End-to-End Integration:From Sequence to LNP products
·Superior Nanoparticle Characterization:QC analytics ensures precision and reliability
·Flexible Scaling Capacity:Manufacturing from 100 μg to 100 mg
·Ready-to-Use mRNA-LNPs:150+ pre-validated mRNA sequence
Service Details
|
Encapsulation Parameters |
QC Specifications |
|
Scale:100 μg-100 mg |
pH:6.0-8.0 |
|
Payload Capacity:100 nt~20 kb mRNA |
Size Distribution:40-180 nm |
|
Cationic Lipids:SM102 / ALC-0315 |
PDI:≤ 0.5 |
|
Turnaround Time:5-8 BD |
Encapsulation Efficiency:≥ 85% |
|
Shipping Condition:Dry ice, Single freeze/thaw cycle |
RNA Content:0.1±0.03 mg/ml |
|
Optional Test Annotation:Zeta、Empty Vesicle Ratio (optional testing require additional charge) |
|
LNP-mediated transfection of mRNA-EGFP in cells
Levostar encapsulated GFP mRNA into LNPs and evaluated delivery efficiency in 293T and A549 cells. The results showed robust GFP expression in both cell types, confirming effective cellular uptake and translation of LNP-formulated mRNA. This demonstrates the potential of LNP-mediated delivery for efficient gene expression across different cell models.
293T Cell
A549 Cell
Fluc mouse fluorescence detection assay
LNP01-1, LNP01-2, LNP01-5, and LNP01-6 were formulated with Fluc mRNA and administered into BALB/c mice. Results confirm that LNP-mediated delivery enables efficient in vivo translation of Fluc mRNA, with distinct formulation-dependent differences in expression levels.
FAQ
What is LNP encapsulation and why is it important for mRNA delivery?
LNP encapsulation is the process of packaging mRNA molecules within lipid nanoparticles to protect them from degradation and facilitate cellular delivery.Efficient encapsulation is critical for ensuring mRNA stability, improving delivery efficiency, and enabling successful protein expression in target cells.
What factors affect LNP encapsulation efficiency?
Encapsulation efficiency is influenced by multiple factors, including lipid composition, mRNA concentration, mixing conditions, and buffer systems.Optimizing these parameters is essential to achieve high loading efficiency, uniform particle size, and consistent performance in downstream applications.
How does microfluidic mixing affect LNP size and encapsulation performance?
Microfluidic mixing enables precise and rapid mixing of lipids and mRNA, resulting in uniform nanoparticle formation with controlled size and low polydispersity.Compared to conventional mixing methods, microfluidics improves reproducibility and encapsulation efficiency, making it a preferred approach for scalable and high-quality LNP production.
What LNP formulations can Levostar provide?
Levostar has more than 15 LNP formulations available, including almost all the published and popular formulations, which can be directly used for research. Levostar also has its own spleen-targeted formulation.
Does Levostar provide LNP encapsulation services for all the catalog mRNAs?
Yes, Levostar provides LNP encapsulation services for more than 200 catalog mRNA, with favorable price. Customized RNA synthesis and LNP encapsulation is also welcome.
Resource
Get in Touch with Levostar
Please send us your request or email to support@levostar.com, our team will contact you as soon as possible.